Nihulugen Tablets (Talniflumate)

Adult dose

Administer orally 370 mg per dose 3 times daily as talniflumate. In severe cases, administer 740 mg per dose. Adjust the dose appropriately according to age and symptoms.

This medication may cause gastrointestinal bleeding in individuals who consume more than three glasses of alcohol daily, so consultation with a physician or pharmacist is essential. This medication may increase the risk of thrombus, myocardial infarction, and stroke in patients with cardiovascular disease or risk factors, so cardiovascular symptoms should be monitored closely. This medication can cause serious gastrointestinal side effects such as gastrointestinal bleeding, ulcers, and perforation, which may carry a higher risk in the elderly; therefore, attention should be paid to gastrointestinal symptoms during use. This medication should not be administered to patients with a history of peptic ulcers or those allergic to this medication or its components, patients with hypersensitivity to aspirin or other non-steroidal anti-inflammatory drugs, patients with severe liver, kidney, or heart disorders, as well as pregnant and nursing women. Patients with mild to moderate liver, kidney, or heart disorders, the elderly, and those allergic to certain dyes should use this medication with caution. This medication may cause various side effects including nausea, vomiting, diarrhea, abdominal pain, skin rash, urticaria, dizziness, and changes in kidney function; if any abnormal symptoms appear, consult a physician immediately. This medication should be administered at the minimum dose for the shortest duration necessary, and regular blood and liver/kidney function tests are required for long-term use. It is advisable not to co-administer this medication with other anti-inflammatory pain relievers, and caution should be taken when used concurrently with certain drugs (ACE inhibitors, aspirin, diuretics, lithium, methotrexate, warfarin, etc.) due to potential interactions. During pregnancy, especially in the later stages, this medication may affect the fetus, so women who are pregnant or may become pregnant should not use it, and nursing mothers should discontinue breastfeeding or the medication while taking this drug. This medication should not be administered to children under 12 years old, and the elderly should be given the minimum dose with caution regarding potential side effects. This medication should be kept out of the reach of children and should not be transferred to another container for safety.

• Nausea
• vomiting
• photosensitivity
• asthma attack
• generalized weakness due to hypotension
• hypersensitivity shock
• diarrhea
• abdominal bloating
• constipation
• dyspepsia

This medication should be stored in a sealed container to prevent exposure to air or moisture. It is advisable to maintain the storage temperature at room temperature, not too hot or too cold.

Appearance

Round yellow film-coated tablet (for domestic use) Orange round film-coated tablet (for export)

Package unit

30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle